These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24639234)

  • 1. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
    Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
    Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.
    Xu H; Paxton JW; Wu Z
    Pharm Res; 2015 Jul; 32(7):2428-38. PubMed ID: 25663325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
    Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
    Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
    Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine.
    Xu H; Li Y; Paxton JW; Wu Z
    Pharm Res; 2021 Jul; 38(7):1209-1219. PubMed ID: 34189639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.
    Xu H; Paxton JW; Wu Z
    Pharm Res; 2016 Jul; 33(7):1628-37. PubMed ID: 26964546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
    Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z
    J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
    Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
    Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
    Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
    Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
    Daman Z; Ostad S; Amini M; Gilani K
    Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Liposomal Gemcitabine with High Drug Loading Capacity.
    Tamam H; Park J; Gadalla HH; Masters AR; Abdel-Aleem JA; Abdelrahman SI; Abdelrahman AA; Lyle LT; Yeo Y
    Mol Pharm; 2019 Jul; 16(7):2858-2871. PubMed ID: 31136710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
    Daman Z; Montazeri H; Azizi M; Rezaie F; Ostad SN; Amini M; Gilani K
    Pharm Res; 2015 Nov; 32(11):3756-67. PubMed ID: 26228105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
    Cosco D; Paolino D; Cilurzo F; Casale F; Fresta M
    Int J Pharm; 2012 Jan; 422(1-2):229-37. PubMed ID: 22093954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma.
    Deodhar S; Dash AK; North EJ; Hulce M
    AAPS PharmSciTech; 2020 Aug; 21(6):231. PubMed ID: 32778980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
    Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
    Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.
    Bornmann C; Graeser R; Esser N; Ziroli V; Jantscheff P; Keck T; Unger C; Hopt UT; Adam U; Schaechtele C; Massing U; von Dobschuetz E
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):395-405. PubMed ID: 17554540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
    Öztürk K; Esendağlı G; Gürbüz MU; Tülü M; Çalış S
    Int J Pharm; 2017 Jan; 517(1-2):157-167. PubMed ID: 27965135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.
    Yugatama A; Huang YL; Hsu MJ; Lin JP; Chao FC; Lam JKW; Hsieh CM
    Int J Nanomedicine; 2024; 19():3753-3772. PubMed ID: 38686338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.